RxBio Funded To Proceed With Developing A Radiation Countermeasure

The development of five new drugs to treat injuries associated with acute radiation syndrome will move forward under contracts awarded by the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA). Acute radiation syndrome is caused by exposure to high doses of damaging (ionizing) radiation. ARS includes injuries to multiple… Read More

Group A Streptococcus Vaccine on Path for Commercialization with Clinical Testing Agreement

An international collaboration between Vaxent, a Memphis-based early stage vaccine development company in the Memphis Bioworks Foundation Incubator, and The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a Centre of Excellence for Commercialization and Research (CECR) in Saskatchewan, has put a vaccine for group A streptococcus (Strep-A) back on the path for potential commercialization. Under the terms… Read More

Tennessee Solar Institute Announces New Solar Installation Grant Recipients

Tennessee Solar Institute (TSI) today announced it has committed nearly $1.6 million in new Solar Installation grants to Tennessee businesses. The grant recipients represent companies that were on a retention list from the first round of funding as well as second-round applicants of the highly popular program. A total of 17 projects, valued at more… Read More